ADVANCE MI-TIMI 29

ADVANCE MI-(TIMI 29) evaluated the efficacy and safety of facilitated PCI following the combination of reduced dose TNK-tpa and eptifibatide compared to primary PCI with eptifibatide alone in 148 patients with primary PCI for STEMI <6h. (Trial ended prematurely). MAIN RESULTS:Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results from the prematurely terminated … Continue reading ADVANCE MI-TIMI 29